EyeQ nanoECP
Laser, Ophthalmic. 510(k) K243014, from Eyeq, Inc. (Reno, NV). Product code HQF, class 2.
As of Nov 17, 2026, K243014 is an FDA 510(k) held by Eyeq, Inc., substantially equivalent on Jun 18, 2025 after 264 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Jun 18, 2025
- Review time: 264 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe EyeQ nanoECP System is indicated for intraoperative photocoagulation of the ciliary processes in the treatment of glaucoma, and for evaluation of the internal ocular structures in patients with dense opacifications of the anterior segment which do not allow a posterior view.
Other HQF Clearances
The newest 510(k)s for the same product code; their median review was 266 days; see every HQF device- Voyager DSLT (430840610)K252979 · Belkin Vision, Ltd. · Apr 7, 2026
- Integre LioK251507 · Quantel Medical · Feb 6, 2026
- Navilas Laser System 577sl (156691)K251772 · Od-Os GmbH · Oct 29, 2025
- Leos Laser and Endoscopy SystemK240615 · Beaver-Visitec International, Inc. · Apr 3, 2025
- LYNX PhotocoagulatorK242397 · Norlase Aps · Oct 25, 2024
- VISULAS combiK233911 · Carl Zeiss Meditec, AG · Sep 6, 2024
- Mr Q; Mr Q Supine; Mr Q SltK232417 · Meridian AG · Jan 25, 2024
- Eagle deviceK230722 · Belkin Vision, Ltd. · Dec 8, 2023
Record
- Type
- Traditional
- Received
- Sep 27, 2024
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.4390
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files